All Type of News
Drug makers to face tough times
Local pharmaceutical firms will face tough times ahead due to the government’s plan to reduce the drug prices depending on expected higher demand.
The Health Insurance Review and Assessment Service (HIRA) is expect...
Conflict escalates over annual salary in Wyeth Korea
Labor union and management of Wyeth Korea will clash over the amount of annual salary for this year as labor union walked away from the table due to an alleged “irreconcilable difference” and requested the Seoul Regio...
Mutual concessions and pain-sharing are essential, Wyeth Korea executives say
Mutual concessions and pain-sharing should be two keywords to tide over the current wage dispute, according to executives of Wyeth Korea.
They claimed it is of course natural that workers demand wage hikes in propo...
Dong-A to receive $17 million in royalties from Trius Therapeutics
Trius Therapeutics, U.S. based pharmaceutical company, is to pay some $17 million in royalties for the development of Dong-A’s new second generation oral and IV oxazolidinone antibiotic (DA-7218), as Trius Therapeutic...
Korea should redefine optimization of medication costsThe Korean government needs to investigate ever-increasing medication costs as part of efforts to understand their optimization size, according to a local professor.
Professo...
|
Pharmaceutical stocks nosedived by 20% on average
Pharmaceutical shares plunged by 20 percent on average as of September 19, when compared to those at January this year.
Sources said drug stocks dropped on panic selling following the collapse of Lehman Brothers, o...
Government told to respect medical and pharmaceutical professionals
The government’s deregulation policy over the nation’s service industry is facing a backlash from healthcare providers.
According to the government, unlicensed people will be able to open specialized businesses as ...
Civic groups call for price reduction of GlivecPatients and civic groups have resubmitted its petition to the Ministry of Health, Welfare and Family Affairs, urging the government to reduce the prices of Glivec to the level ...
|
Daewon to launch new anti-inflammatory drug in OctoberDaewon Pharm plans to launch its new nonsteroidal anti-inflammatory drug, Peluvi tablets (felubiprofen) from next month as the drug is eligible for the national health insurance...
|
Wyeth BioPharma exc. vice chairman visits Korea
Robert Repella, Executive Vice-President and General Manager of Wyeth BioPharma, made his visit to Seoul between September 22 and 23.
During his two-day visit, Repella had an opportunity to introduce the company's...
